蛋白质表征市场－全球产业规模、份额、趋势、机会和预测（按产品与服务、应用、最终用途、地区和竞争细分，2020-2030 年）

2024 年全球蛋白质表征市场价值为 154.5 亿美元，预计到 2030 年将达到 340.7 亿美元，复合年增长率为 14.06%。随着人们越来越重视蛋白质体学及其在理解细胞功能和疾病机制中的作用，全球蛋白质表征市场正在强劲扩张。蛋白质作为关键的生物标记和治疗标靶，是药物发现、诊断和个人化医疗的核心。这促使生物技术和製药公司投资先进的蛋白质分析技术。质谱、色谱和电泳等工具被广泛用于研究蛋白质结构、翻译后修饰和相互作用。对精准医疗和生物製剂的需求不断增长，进一步加速了对精确蛋白质分析的需求。政府对生命科学研究的资助不断增加，学术机构和产业参与者之间的合作不断增多，这些都支持着市场的扩张。

塑造市场的趋势包括将人工智慧和机器学习融入蛋白质分析，从而加快资料处理和预测建模速度。自动化和高通量筛选技术正在缩短分析时间并提高可重复性，使蛋白质表征在大规模应用中更有效率。多组学方法的出现，将蛋白质组学与基因组学和代谢组学相结合，正在加深对生物学的洞察，并促进全面分析。微型化和晶片实验室平台在即时诊断应用（尤其是在临床诊断领域）中越来越受欢迎。业内人士也致力于开发用户友好的软体工具，以实现无缝的资料整合、解读和视觉化，帮助研究人员加速发现。

关键市场驱动因素

生物製剂和生物相似药需求不断增长

主要市场挑战

仪器和分析服务成本高昂

主要市场趋势

单株抗体和生物製剂开发的兴起

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球蛋白质表征市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品及服务（消耗品、仪器、服务）
  • 按应用（药物研发、临床诊断、其他）
  • 依最终用途（製药和生物技术公司、学术研究机构、合约研究组织、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美蛋白质表征市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲蛋白质表征市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太蛋白质表征市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲蛋白质表征市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲蛋白质表征市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Eurofins Scientific
• Merck KGAA
• Promega Corporation
• Qiagen NV
• Sartorius AG

第 15 章：策略建议

第16章调查会社について・免责事项

Global Protein Characterization Market was valued at USD 15.45 Billion in 2024 and is expected to reach USD 34.07 Billion by 2030 with a CAGR of 14.06%. The Global Protein Characterization Market is witnessing robust expansion due to the growing emphasis on proteomics and its role in understanding cellular functions and disease mechanisms. Proteins, being key biomarkers and therapeutic targets, are central to drug discovery, diagnostics, and personalized medicine. This has prompted biotechnology and pharmaceutical companies to invest in advanced protein analysis technologies. Tools such as mass spectrometry, chromatography, and electrophoresis are widely used to study protein structure, post-translational modifications, and interactions. Increasing demand for precision medicine and biologics has further accelerated the need for accurate protein profiling. Rising government funding for life sciences research and an uptick in collaborations between academic institutions and industry players are supporting the market's expansion.

Trends shaping the market include the integration of artificial intelligence and machine learning in protein analysis, enabling faster data processing and predictive modeling. Automation and high-throughput screening technologies are reducing analysis time and improving reproducibility, making protein characterization more efficient for large-scale applications. The emergence of multi-omics approaches, combining proteomics with genomics and metabolomics, is enhancing the depth of biological insights and encouraging comprehensive profiling. Miniaturized and lab-on-chip platforms are gaining traction for point-of-care applications, especially in clinical diagnostics. Industry players are also focusing on developing user-friendly software tools that allow seamless data integration, interpretation, and visualization, helping researchers accelerate discoveries.

Key Market Drivers

Rising Demand for Biologics and Biosimilars

The increasing demand for biologics and biosimilars is a significant driver for the Global Protein Characterization Market. Biologics, including monoclonal antibodies, therapeutic proteins, and vaccines, are revolutionizing the treatment of various diseases, particularly in oncology, autoimmune disorders, and genetic diseases. As these therapies continue to grow in importance, the need for precise and comprehensive protein characterization and identification becomes crucial. Protein characterization techniques allow for the analysis of protein structures, functions, and interactions, which is vital for ensuring the safety, efficacy, and quality of biologic drugs.

In 2023, the U.S. Food and Drug Administration (FDA) approved 55 new drugs, of which 17 were biologics, accounting for 30.9% of all drug approvals. Notably, 12 of these biologics were monoclonal antibodies, marking a significant milestone in biologic drug development. The Center for Biologics Evaluation and Research (CBER) added 23 new biologics license application approvals in 2023, highlighting the growing focus on biologic therapies.

Similarly, the European Medicines Agency (EMA) recommended 77 medicines for marketing authorization in 2023, with 39 having a new active substance. This indicates a strong emphasis on innovative therapies, including biologics, in the European market.

The increasing focus on biosimilars, which are similar to original biologic drugs but at a lower cost, further fuels the demand for protein characterization. As the patents of several blockbuster biologics expire, pharmaceutical companies are investing heavily in the development of biosimilars to tap into this growing market. Ensuring the structural and functional similarity of biosimilars to their reference biologics is critical, and this requires advanced protein characterization methods such as mass spectrometry, chromatography, and peptide mapping.

Regulatory agencies worldwide, including the FDA and EMA, have established rigorous guidelines to assess the quality and safety of biologics and biosimilars, which in turn drives the need for precise protein identification techniques. As biologic therapies gain popularity and the biosimilars market expands, the demand for protein characterization and identification solutions will continue to rise, accelerating market growth and innovation in this sector.

Key Market Challenges

High Cost of Instruments and Analytical Services

The high cost of instruments and analytical services remains a significant challenge for the Global Protein Characterization Market. Cutting-edge protein characterization tools such as mass spectrometers, chromatography systems, and protein analyzers are critical for accurate and reliable results. These advanced instruments often come with hefty price tags, making them unaffordable for smaller research institutions, universities, and laboratories, particularly in emerging markets. The expense associated with these technologies can create a barrier to entry for organizations with limited financial resources, thereby hindering widespread adoption of advanced protein characterization methods.

Beyond the high initial purchase cost, maintaining and operating these instruments requires specialized training, skilled personnel, and regular servicing, all of which add to the ongoing expenses. The need for highly trained technicians and scientists to operate these advanced technologies further drives up operational costs. Additionally, the reliance on specialized reagents and consumables for protein analysis can contribute to the overall expense. For many research entities, these financial constraints may limit the frequency of protein characterization studies and the scope of their research projects.

Key Market Trends

Rise in Monoclonal Antibody and Biologics Development

The rise in monoclonal antibody (mAb) and biologics development is significantly driving the Global Protein Characterization Market. With the growing emphasis on biologic therapies, including monoclonal antibodies, protein characterization and identification have become essential to ensuring the safety, efficacy, and consistency of these therapies. As biologics are increasingly utilized for treating chronic diseases, cancers, and autoimmune conditions, accurate protein analysis is vital to understanding their molecular structures, functionality, and therapeutic potential. This trend is particularly pronounced with the growing use of mAbs, which are highly complex molecules that require precise characterization for both drug development and regulatory approval.

The growing complexity of biologics has led to increased demand for advanced proteomics tools, such as mass spectrometry and chromatography, to analyze proteins and their interactions. This demand is expected to rise as the pharmaceutical industry focuses on personalized medicine, where the detailed profiling of proteins in the context of individual patients is crucial. Accurate protein identification is pivotal in the development of next-generation biologics, as even slight structural variations can impact the therapeutic outcome.

Key Market Players

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Eurofins Scientific
• Merck KGAA
• Promega Corporation
• Qiagen N.V.
• Sartorius AG

Report Scope:

In this report, the Global Protein Characterization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Characterization Market, By Product & Services:

• Consumables
• Instruments
• Services

Protein Characterization Market, By Application:

• Drug Discovery & Development
• Clinical Diagnosis
• Others

Protein Characterization Market, By End-Use:

• Pharmaceuticals & Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Others

Protein Characterization Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Characterization Market.

Available Customizations:

Global Protein Characterization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Protein Characterization Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Services (Consumables, Instruments, Services)
  • 5.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
  • 5.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Protein Characterization Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Services
  • 6.2.2. By Application
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Protein Characterization Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Services
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Mexico Protein Characterization Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Services
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Canada Protein Characterization Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Services
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-Use

7. Europe Protein Characterization Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Services
  • 7.2.2. By Application
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Protein Characterization Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Services
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-Use
  • 7.3.2. Germany Protein Characterization Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Services
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Protein Characterization Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Services
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Protein Characterization Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Services
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Protein Characterization Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Services
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-Use

8. Asia-Pacific Protein Characterization Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Services
  • 8.2.2. By Application
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Protein Characterization Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Services
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Protein Characterization Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Services
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-Use
  • 8.3.3. South Korea Protein Characterization Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Services
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-Use
  • 8.3.4. Japan Protein Characterization Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Services
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Protein Characterization Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Services
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-Use

9. South America Protein Characterization Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Services
  • 9.2.2. By Application
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Protein Characterization Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Services
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-Use
  • 9.3.2. Argentina Protein Characterization Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Services
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-Use
  • 9.3.3. Colombia Protein Characterization Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Services
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-Use

10. Middle East and Africa Protein Characterization Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Services
  • 10.2.2. By Application
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Protein Characterization Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Services
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Saudi Arabia Protein Characterization Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Services
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-Use
  • 10.3.3. UAE Protein Characterization Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Services
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Agilent Technologies, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Bio-Rad Laboratories, Inc.
• 14.3. Bruker Corporation
• 14.4. Thermo Fisher Scientific Inc.
• 14.5. Danaher Corporation
• 14.6. Eurofins Scientific
• 14.7. Merck KGAA
• 14.8. Promega Corporation
• 14.9. Qiagen N.V.
• 14.10. Sartorius AG

15. Strategic Recommendations

16. About Us & Disclaimer